These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 1220976)

  • 21. Value of cytosine arabinoside (NSC-63878) plus 5-(3,3-dimethyl-1-triazeno)imidazole-4-carboxamide (NSC-45388) therapy in advanced murine L1210 leukemia and enhancement of the combination with sequential doses of methotrexate (NSC-740) or 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU; NSC-409962).
    Kline I; Woodman RJ; Gang M; Cysyk RL; Venditti JM
    Cancer Chemother Rep; 1973; 57(3):291-8. PubMed ID: 4751255
    [No Abstract]   [Full Text] [Related]  

  • 22. Selective chemotherapy for advanced murine L 1210 leukemia by combination of 2' deoxycytidine and lethal doses of cytosine-arabinoside.
    Buchman VM; Svet-Maoldavsky GJ; Lichinitser MR; Mkheidze DM
    Biomedicine; 1977 Jul; 27(5):179-80. PubMed ID: 922116
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of combined therapy with cytosine arabinoside (NSC-63878) and l,3-bis-(2-chloroethyl)-1-nitrosourea (NSC-409962) on sarcoma 180 and L1210 in vivo.
    Mizuno NS; Humphrey EW
    Cancer Chemother Rep; 1969 Sep; 53(4):215-21. PubMed ID: 5384462
    [No Abstract]   [Full Text] [Related]  

  • 24. A computer model for tumor growth and chemotherapy, and its application to L1210 leukemia treated with cytosine arabinoside (NSC-63878).
    Shackney SE
    Cancer Chemother Rep; 1970 Dec; 54(6):399-429. PubMed ID: 5527022
    [No Abstract]   [Full Text] [Related]  

  • 25. Response to therapy of spontaneous, first passage, and long passage lines of AK leukemia.
    Skipper HE; Schabel FM; Trader MW; Laster WR
    Cancer Chemother Rep; 1969 Dec; 53(6):345-66. PubMed ID: 5384468
    [No Abstract]   [Full Text] [Related]  

  • 26. Letter: Proposed new derivative of cytosine arabinoside (NSC-63878) to circumvent resistance.
    Cysyk RL
    Cancer Chemother Rep; 1974; 58(3):298-9. PubMed ID: 4842665
    [No Abstract]   [Full Text] [Related]  

  • 27. Synchronization of cell division in vivo through the combined use of cytosine arabinoside and Colcemid.
    Verbin RS; Diluiso G; Liang H; Farber E
    Cancer Res; 1972 Jul; 32(7):1489-95. PubMed ID: 5030577
    [No Abstract]   [Full Text] [Related]  

  • 28. [Experimental combination chemotherapy of YNK01, a novel analog of cytarabine, with other antitumor agents].
    Uchida T; Nagahata T; Arakawa M; Ekimoto H; Takahashi K
    Gan To Kagaku Ryoho; 1990 Jul; 17(7):1351-6. PubMed ID: 2114829
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Activity of benzimidazole carbamates against L1210 mouse leukaemia cells: correlation with in vitro tubulin polymerization assay.
    Lacey E; Watson TR
    Biochem Pharmacol; 1985 Oct; 34(19):3603-5. PubMed ID: 4052102
    [No Abstract]   [Full Text] [Related]  

  • 30. The effects of R U7934 (NSC 238159), a new antimicrotubular substance, on the ultrastructure of neoplastic cells in vivo.
    De Brabander M; Geuens G; Van De Veire R; Thoneé F; Aerts F; Desplenter L; De Cree J; Borgers M
    Eur J Cancer (1965); 1977 Jun; 13(6):511-28. PubMed ID: 880961
    [No Abstract]   [Full Text] [Related]  

  • 31. Enhanced antitumor effect of cytosine arabinoside given in a schedule dictated by kinetic studies in vivo.
    Young RC; Goldberg D; Schein PS
    Biochem Pharmacol; 1973 Jan; 22(2):277-80. PubMed ID: 4763256
    [No Abstract]   [Full Text] [Related]  

  • 32. Combination therapy of mouse leukemia L1210 by 1-beta-D-arabinofuranosylcytosine and 6-[(4-nitrobenzyl)thio]-9-beta-D-ribofuranosylpurine.
    Cass CE; Muzik H; Paterson AR
    Cancer Res; 1975 May; 35(5):1187-93. PubMed ID: 1120308
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antitumor activity of pyrazofurin in combination with 5-azacytidine against murine P388 and L1210 leukemias and colon carcinoma 26.
    Chiuten DF; Muggia FM; Johnson RK
    Cancer Treat Rep; 1979; 63(11-12):1857-62. PubMed ID: 93512
    [No Abstract]   [Full Text] [Related]  

  • 34. Experimental and clinical studies on nucleoside analogs as antitumor agents.
    Burchenal JH; Currie VE; Dowling MD; Fox JJ; Krakoff IH
    Ann N Y Acad Sci; 1975 Aug; 255():202-12. PubMed ID: 1059355
    [No Abstract]   [Full Text] [Related]  

  • 35. Leukemia cell lines resistant to cytosine arabinoside, cyclophosphamide or daunomycin are equally sensitive to the drug acetyldinaline as the parental cell line.
    El-Beltagi HM; Martens AC; Hagenbeek A
    Leukemia; 2000 Jan; 14(1):213-4. PubMed ID: 10637498
    [No Abstract]   [Full Text] [Related]  

  • 36. [Studies on the relationship between therapeutic schedule and antitumor effect of etoposide and cytosine arabinoside in murine L1210 leukemia].
    Ooi K; Ohkubo T; Kawasaki H; Sakurai M
    Yakugaku Zasshi; 1989 Nov; 109(11):865-8. PubMed ID: 2614669
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Influence of continuous infusion of cytosine arabinoside on sequencing with daunorubicin in L1210 leukemia.
    Edelstein M; Valeriote F; Vietti T
    Cancer Treat Rep; 1978 Apr; 62(4):547-8. PubMed ID: 657151
    [No Abstract]   [Full Text] [Related]  

  • 38. [Cellular mechanism of the antileukemic action of quinoline dibromide].
    Golenko OD; Paramonova TD; Nikolaeva TG
    Biull Eksp Biol Med; 1984 Jul; 98(7):59-61. PubMed ID: 6466833
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of 4,4'-diacetyl-diphenyl-urea-bis(guanylhydrazone) on leukemia L1210.
    Mihich E; Mulhern AI
    Cancer Res; 1968 Feb; 28(2):354-62. PubMed ID: 5641525
    [No Abstract]   [Full Text] [Related]  

  • 40. Stathmokinetic and therapeutic effects of maytansine in mice bearing P388 and L1210 leukemias.
    Johnson RK; Inouye T; Wolpert-DeFilippes MK
    Biochem Pharmacol; 1978; 27(15):1973-5. PubMed ID: 708479
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.